Elke E.M. Peters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elke E.M. Peters has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Carla Bartosch
Department of Pathology, Instituto Português de Oncologia do Porto, Porto, Portugal
1 shared publication Catherine Genestie
Department of BioPathology, University Paris-Saclay, Gustave-Roussy Cancer Center, Villejuif, France
1 shared publicationHuub C S H Smit
Department of Pathological Anatomy, Ghent University Hospital, Ghent, Belgium
1 shared publicationJan Oosting
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publicationJan W. van ‘t Wout
Department of Internal Medicine, HMC Bronovo, The Hague, Netherlands
1 shared publication- Justin Jacobse
Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 2 June 2019
- Published by Wiley in Histopathology
- Vol. 75 (1) , 128-136
Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer
Aims: Lymphovascular space invasion (LVSI) in endometrial cancer (EC) is an important prognostic variable impacting on a patient's individual recurrence risk and adjuvant treatment recommendations. Recent work has shown that grading the extent of LVSI further improves its prognostic strength in patients with stage I endometrioid EC. Despite this, there is little information on the reproducibility of LVSI assessment in EC. Therefore, we designed a study to evaluate interobserver agreement in discriminating true LVSI from LVSI mimics (Phase I) and reproducibility of grading extent of LVSI (Phase II).Methods and results: Scanned haematoxylin and eosin (H&E) slides of endometrioid EC (EEC) with a predefined possible LVSI focus were hosted on a website and assessed by a panel of six European gynaecological pathologists. In Phase I, 48 H&E slides were included for LVSI assessment and in Phase II, 42 H&E slides for LVSI grading. Each observer was instructed to apply the criteria for LVSI used in daily practice. The degree of agreement was measured using the two‐way absolute agreement average‐measures intraclass correlation coefficient (ICC). Reproducibility of LVSI assessment (ICC = 0.64, P < 0.001) and LVSI grading (ICC = 0.62, P < 0.001) in EEC was substantial among the observers.Conclusions: Given the good reproducibility of LVSI, this study further supports the important role of LVSI in decision algorithms for adjuvant treatment.
- 2 June 2019
- Published by Wiley in Histopathology
- Vol. 75 (1) , 128-136
Open AccessReproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer
Aims: Lymphovascular space invasion (LVSI) in endometrial cancer (EC) is an important prognostic variable impacting on a patient's individual recurrence risk and adjuvant treatment recommendations. Recent work has shown that grading the extent of LVSI further improves its prognostic strength in patients with stage I endometrioid EC. Despite this, there is little information on the reproducibility of LVSI assessment in EC. Therefore, we designed a study to evaluate interobserver agreement in discriminating true LVSI from LVSI mimics (Phase I) and reproducibility of grading extent of LVSI (Phase II).Methods and results: Scanned haematoxylin and eosin (H&E) slides of endometrioid EC (EEC) with a predefined possible LVSI focus were hosted on a website and assessed by a panel of six European gynaecological pathologists. In Phase I, 48 H&E slides were included for LVSI assessment and in Phase II, 42 H&E slides for LVSI grading. Each observer was instructed to apply the criteria for LVSI used in daily practice. The degree of agreement was measured using the two‐way absolute agreement average‐measures intraclass correlation coefficient (ICC). Reproducibility of LVSI assessment (ICC = 0.64, P < 0.001) and LVSI grading (ICC = 0.62, P < 0.001) in EEC was substantial among the observers.Conclusions: Given the good reproducibility of LVSI, this study further supports the important role of LVSI in decision algorithms for adjuvant treatment.
- Open Access
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (4) , 158-162
Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases
Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (4) , 158-162
Open AccessVasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases
Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases